What We Do
By talking and working with you months or even years before you disclose an innovation, we can help you maximize the impact of your work without compromising your research goals.
If it’s your first time working with us, the first step is to submit a Consultation Request so that we can match you with an Innovation Manager knowledgeable about your area of research. Our Innovation Managers have advanced degrees and extensive experience in a broad range of high-demand technical areas.
If you have questions feel free to reach out to us at firstname.lastname@example.org or (206) 543-3970.
WORK WITH US EARLY TO MAXIMIZE IMPACT
As the first stage of the Innovation Process, it is a critical point of connection between you and the Innovation Manager. An Innovation Manager will consult with you on your innovation to determine next steps and collaborate on possibilities. We will review steps to protect your research for:
Actively connect to establish a relationship with the CoMotion office prior to any activities related to your innovation, if possible. Schedule a meeting now to discuss all of your options!
An in-person meeting with your Innovation Manager in order to establish the relationship, review the process, and identify next steps.
The formative stages before launching a new technology company typically last 12-18 months. Before launch a UW Startup Project prepares its market strategy, strengthens its startup team, identifies key milestones toward securing customers or investors, and builds prototypes to support these milestones. CoMotion® provides planning and resources to promote higher-quality startup projects.
CoMotion also makes resources available to young UW Startup Companies. Although a startup opportunity may be compelling enough to launch, it usually faces a challenging period of refining its offering in order to engage early customers and grow toward stability. By providing a comprehensive system of resources for technology entrepreneurship, we have resources available for other distribution models.
Innovation training exposes the University of Washington and greater Seattle area communities to innovative thinking through workshops and events which integrate, for example, design thinking and lean canvas methods. Innovation Training also supports the University of Washington’s Innovation Imperative by developing programs that expose students, faculty, and staff to innovative thinking and the innovation ecosystem.
For more information contact Magali Eaton at CoMtrain@uw.edu.
The Biological Materials portfolio consists of non-patented biological materials such as transgenic mice, antibodies, cell lines, and vectors. In the majority of cases we will not file for patent protection of such materials as they can be effectively commercialized in the absence of patent protection.
Biological Materials that will be transferred to non-profits or universities would go through our Agreements Group under the standard outgoing Materials Transfer Agreement (MTA).
To transfer these tools to for-profit institutions such as a biotech or pharmaceutical company, we need to have appropriate agreements in place. We may be able to make the Biological Material available for a fee as a research reagent (sold to other end users) or for internal research use only. However, there may be third-party rights involved in the material -- for example:
For the transfer of any Biological Material, the UW Investigator will be responsible for preparing and shipping the material.
LINKS TO POLICIES AND REPORTS AT THE UW AND STATE OF WASHINGTON.
The Executive Orders (EO) provide the foundation for the policy at the UW. Details about current operation and implementation are found in the Administrative Policy Statements (APS) and Grants Information Memoranda (GIM). The references provided below are intended only as a starting point on this broad topic. See the UW Policy Directory for a comprehensive treatment of the policies governing activities at the UW.
Jeanette Ennis supports UW researchers pursuing grant money to commercialize their innovations, and helps CoMotion secure economic development grant opportunities. Ennis joined CoMotion in 2009 after more than 15 years of broad research experience as a scientist, entrepreneur, and manager. Her areas of expertise include pharmacology, biochemistry, molecular biology, tissue engineering, and medical devices. She has worked with a variety of start-up companies as project manager, grant writer, and intellectual property manager, and held senior research positions at Cornell University and the UW Department of Cardiothoracic Surgery. She earned a doctorate in medical and molecular pharmacology from the University of California, Los Angeles, where she trained with Louis Ignarro, Nobel Laureate in Physiology. She also holds a certificate in technical writing and editing from the UW Department of Human Centered Design & Engineering.